ACB
Aurora Cannabis, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$5.17
+0.10%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$5.17
From 52W high−7.27%
Volume1.51M
Market cap$327.00M
P/E (TTM)—
P/S (TTM)1.6x
Div yield—
Key dataNov 4, 2026
Open
$5.17
From 52W high
−7.27%
Volume
1.51M
Market cap
$327.00M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−4.9x
P/E (TTM)
—
RSI (14)
76.6
MomentumView details →
1D Return
+0.10%
YTD Return
+20.23%
SummaryUpdated Jun 1, 2026
Aurora Cannabis Inc. (NASDAQ:ACB) is a Canadian cannabis company founded in 2006 and publicly traded since 2014. Originally established as a medical cannabis producer, Aurora has evolved into one of the world's largest cannabis companies with operations spanning cultivation, production, and distribution across multiple international markets. The company is headquartered in Edmonton, Alberta, and has undergone significant strategic transformation over the past few years, pivoting from a growth-at-all-costs model to a focused, profitability-driven approach centered on high-margin medical cannabis markets globally.
Similar companies
Latest newsMore news →
ORGANIGRAM GLOBAL INC. agreed to buy AURORA CANNABIS INC amid a hostile bid from Curaleaf Holdings, Inc..1d agoOrganigram announced an agreement to acquire all issued and outstanding common shares of Aurora for C$7.80 per share.1d agoAURORA CANNABIS INC is evaluating strategic alternatives in response to Curaleaf Holdings, Inc.'s hostile takeover bid, including a potential third-party transaction or remaining independent, to maximize shareholder value.19d ago